Suppr超能文献

腺苷诱导的心脏停搏可作为颅内动脉瘤手术中临时夹闭的替代方法。

Adenosine-induced cardiac arrest as an alternative to temporary clipping during intracranial aneurysm surgery.

机构信息

1Department of Neurosurgery, Helsinki University Hospital, Helsinki, Finland.

Departments of2Anesthesiology and.

出版信息

J Neurosurg. 2018 Sep;129(3):684-690. doi: 10.3171/2017.5.JNS162469. Epub 2017 Oct 27.

Abstract

OBJECTIVE The purpose of this study was to analyze the impact of adenosine-induced cardiac arrest (AiCA) on temporary clipping (TC) and the postoperative cerebral infarction rate among patients undergoing intracranial aneurysm surgery. METHODS In this retrospective matched-cohort study, 65 patients who received adenosine for decompression of aneurysms during microsurgical clipping were identified (Group A) and randomly matched with 65 selected patients who underwent clipping but did not receive adenosine during surgery (Group B). The matching criteria included age, Fisher grade, aneurysm size, rupture status, and location of aneurysms. The primary outcomes were TC time and the postoperative infarction rate. The secondary outcome was the incidence of intraoperative aneurysm rupture (IAR). RESULTS In Group A, 40 patients underwent clipping with AiCA alone and 25 patients (38%) received AiCA combined with TC, and in Group B, 60 patients (92%) underwent aneurysm clipping under the protection of TC (OR 0.052; 95% CI 0.018-0.147; p < 0.001). Group A required less TC time (2.04 minutes vs 4.46 minutes; p < 0.001). The incidence of postoperative lacunar infarction was equal in both groups (6.2%). There was an insignificant between-group difference in the incidence of IAR (1.5% in Group A vs 6.1% in Group B; OR 0.238; 95% CI 0.026-2.192; p = 0.171). CONCLUSIONS AiCA is a useful technique for microneurosurgical treatment of cerebral aneurysms. AiCA can minimize the use of TC and does not increase the risk of IAR and postoperative infarction.

摘要

目的 本研究旨在分析腺苷诱导的心脏骤停(AiCA)对颅内动脉瘤手术患者临时夹闭(TC)和术后脑梗死发生率的影响。

方法 在这项回顾性匹配队列研究中,确定了 65 例在显微镜夹闭术中因动脉瘤减压而接受腺苷的患者(A 组),并随机匹配了 65 例接受夹闭但术中未接受腺苷的患者(B 组)。匹配标准包括年龄、Fisher 分级、动脉瘤大小、破裂状态和动脉瘤位置。主要结局是 TC 时间和术后梗死发生率。次要结局是术中动脉瘤破裂(IAR)的发生率。

结果 在 A 组中,40 例患者单独行 AiCA 夹闭,25 例(38%)患者接受 AiCA 联合 TC,在 B 组中,60 例(92%)患者在 TC 保护下行动脉瘤夹闭(OR 0.052;95%CI 0.018-0.147;p<0.001)。A 组的 TC 时间更短(2.04 分钟 vs 4.46 分钟;p<0.001)。两组术后腔隙性梗死发生率相等(6.2%)。A 组 IAR 的发生率与 B 组无显著差异(1.5% vs 6.1%;OR 0.238;95%CI 0.026-2.192;p=0.171)。

结论 AiCA 是一种治疗颅内动脉瘤的有用技术。AiCA 可以最大限度地减少 TC 的使用,并且不会增加 IAR 和术后梗死的风险。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验